These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22829765)

  • 1. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China.
    Lessler J; Riley S; Read JM; Wang S; Zhu H; Smith GJ; Guan Y; Jiang CQ; Cummings DA
    PLoS Pathog; 2012; 8(7):e1002802. PubMed ID: 22829765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
    Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
    Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.
    Kucharski AJ; Lessler J; Read JM; Zhu H; Jiang CQ; Guan Y; Cummings DA; Riley S
    PLoS Biol; 2015 Mar; 13(3):e1002082. PubMed ID: 25734701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization titers against influenza A (H3N2) and influenza B viruses among a non-vaccinated population from Thailand.
    Boonsathorn N; Kanai Y; Punjumpa J; Bai G; Chittaganpitch M; Petphuwadee U; Jampangern W; Sawanpanyalert P; Ikuta K; Teerasut C
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):674-9. PubMed ID: 23077847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
    Chen LL; Wu WL; Chan WM; Fong CHY; Ng ACK; Ip JD; Lu L; Dissanayake TK; Ding X; Cai JP; Zhang AJX; Tam S; Hung IFN; Chan KH; Yuen KY; To KKW
    Epidemiol Infect; 2019 Sep; 147():e279. PubMed ID: 31556360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth cohort relative to an influenza A virus's antigenic cluster introduction drives patterns of children's antibody titers.
    Brouwer AF; Balmaseda A; Gresh L; Patel M; Ojeda S; Schiller AJ; Lopez R; Webby RJ; Nelson MI; Kuan G; Gordon A
    PLoS Pathog; 2022 Feb; 18(2):e1010317. PubMed ID: 35192673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.
    Miller MS; Gardner TJ; Krammer F; Aguado LC; Tortorella D; Basler CF; Palese P
    Sci Transl Med; 2013 Aug; 5(198):198ra107. PubMed ID: 23946196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
    Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD
    Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population susceptibility to North American and Eurasian swine influenza viruses in England, at three time points between 2004 and 2011.
    Hoschler K; Thompson C; Casas I; Ellis J; Galiano M; Andrews N; Zambon M
    Euro Surveill; 2013 Sep; 18(36):pii=20578. PubMed ID: 24079379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A.
    Truelove S; Zhu H; Lessler J; Riley S; Read JM; Wang S; Kwok KO; Guan Y; Jiang CQ; Cummings DA
    Influenza Other Respir Viruses; 2016 Nov; 10(6):518-524. PubMed ID: 27406695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life course exposures continually shape antibody profiles and risk of seroconversion to influenza.
    Yang B; Lessler J; Zhu H; Jiang CQ; Read JM; Hay JA; Kwok KO; Shen R; Guan Y; Riley S; Cummings DAT
    PLoS Pathog; 2020 Jul; 16(7):e1008635. PubMed ID: 32702069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.
    Radin JM; Hawksworth AW; Ortiguerra RG; Brice GT
    PLoS One; 2015; 10(3):e0121037. PubMed ID: 25816244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus.
    Kohler I; Scherrer AU; Zagordi O; Bianchi M; Wyrzucki A; Steck M; Ledergerber B; Günthard HF; Hangartner L
    Clin Infect Dis; 2014 Nov; 59(10):1386-93. PubMed ID: 25139962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority.
    Sicca F; Sakorafa E; de Jonge A; de Vries-Idema J; Zhou F; Cox RJ; Huckriede A
    Front Immunol; 2022; 13():987984. PubMed ID: 36119111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.